Liping Zhou
Research Subjects
Research Interests
Liping Zhou has a total of 254 co-authors. Here are the top co-authors by number of shared publications:
Gang Liu
Novartis Institutes for BioMedical Research , 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, United States
3 shared publicationsLaszlo Urban
Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA
3 shared publicationsMats Holmqvist
Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA
3 shared publicationsQiang Lu
Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA
3 shared publicationsXueying Cao
Novartis Institutes for BioMedical Research, Inc., 250 Massachusetts Avenue, Cambridge, MA 02139, USA
3 shared publications- Annette Bak
Advanced Drug Delivery, AstraZeneca R&D, Boston MA, USA
2 shared publications
Latest Publications
- 4 September 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (10) , 5033-5043
Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions
The solubility advantage of an amorphous drug can be realized only when it releases at a sufficiently rapid rate from its amorphous solid dispersion (ASD). Herein, we evaluated the impact of a plasticizer, glyceryl tributyrate (GTB), on the release of a poorly soluble drug with a high glass transition temperature (Tg). Cyclosporine has a Tg of 124 °C and was formulated as an ASD with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Binary and ternary ASDs were prepared using solvent evaporation, their Tgs were measured using differential scanning calorimetry, and surface area normalized release rates were determined. The drug-rich phase formed above the amorphous solubility was characterized for composition and size. Drug flux following release from the ASD was measured across Caco-2 cell monolayers. Cyclosporine released at a substantially faster rate from ternary ASDs containing GTB as compared to the corresponding binary ASD. This improvement was attributed to a decrease in Tg upon plasticization due to GTB increasing molecular mobility. Addition of GTB, however, reduced the amorphous solubility of cyclosporine resulting in a decrease in the transport rate across the Caco-2 cell monolayer. These observations may have implications for drug absorption. Ultimately, it is expected that the in vivo performance of these ternary ASDs would be determined by the interplay between the enhanced release rate and the decreased permeation rate of the drug.
- 4 September 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (10) , 5033-5043
Balancing Release and Permeation Rates in Cyclosporine Amorphous Solid Dispersions
The solubility advantage of an amorphous drug can be realized only when it releases at a sufficiently rapid rate from its amorphous solid dispersion (ASD). Herein, we evaluated the impact of a plasticizer, glyceryl tributyrate (GTB), on the release of a poorly soluble drug with a high glass transition temperature (Tg). Cyclosporine has a Tg of 124 °C and was formulated as an ASD with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Binary and ternary ASDs were prepared using solvent evaporation, their Tgs were measured using differential scanning calorimetry, and surface area normalized release rates were determined. The drug-rich phase formed above the amorphous solubility was characterized for composition and size. Drug flux following release from the ASD was measured across Caco-2 cell monolayers. Cyclosporine released at a substantially faster rate from ternary ASDs containing GTB as compared to the corresponding binary ASD. This improvement was attributed to a decrease in Tg upon plasticization due to GTB increasing molecular mobility. Addition of GTB, however, reduced the amorphous solubility of cyclosporine resulting in a decrease in the transport rate across the Caco-2 cell monolayer. These observations may have implications for drug absorption. Ultimately, it is expected that the in vivo performance of these ternary ASDs would be determined by the interplay between the enhanced release rate and the decreased permeation rate of the drug.
- 25 March 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (4) , 2385-2397
Addressing the Release and Permeation Challenges of High- T g Drugs in Amorphous Solid Dispersions
The goal of the current study was to assess the release rate of model high glass transition temperature (Tg) drugs from amorphous solid dispersions (ASDs) as a function of drug loading, and then to evaluate the permeation rate of the resultant solutions using Caco-2 cells. Ivacaftor and ARV-825 were selected as model drugs and were formulated as ASDs with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Release was found to be very slow or not detectable at higher drug loadings. Dramatically improved release was observed upon addition of 10 wt % glyceryl tributyrate to the ASDs, which reduced Tg. Nanosized drug-rich amorphous droplets, generated upon dissolution of ivacaftor ASDs, enhanced the Caco-2 membrane permeation rate, likely by partitioning into the unstirred water layer (UWL) at the surface of the membrane and reducing the concentration gradient across the UWL. The extent of improvement was correlated with the size of droplets: smaller droplets resulted in faster permeation rates. Addition of glyceryl tributyrate, while increasing the release rate, decreased the permeation rate due to formation of larger droplets. In conclusion, the addition of a plasticizer to an ASD containing a high Tg drug led to an improvement in release rate but increased the size of drug-rich nanodroplets produced via the release process with unknown potential implications for in vivo performance.
- 25 March 2026
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (4) , 2385-2397
Addressing the Release and Permeation Challenges of High- T g Drugs in Amorphous Solid Dispersions
The goal of the current study was to assess the release rate of model high glass transition temperature (Tg) drugs from amorphous solid dispersions (ASDs) as a function of drug loading, and then to evaluate the permeation rate of the resultant solutions using Caco-2 cells. Ivacaftor and ARV-825 were selected as model drugs and were formulated as ASDs with hydroxypropyl methylcellulose acetate succinate (HPMCAS). Release was found to be very slow or not detectable at higher drug loadings. Dramatically improved release was observed upon addition of 10 wt % glyceryl tributyrate to the ASDs, which reduced Tg. Nanosized drug-rich amorphous droplets, generated upon dissolution of ivacaftor ASDs, enhanced the Caco-2 membrane permeation rate, likely by partitioning into the unstirred water layer (UWL) at the surface of the membrane and reducing the concentration gradient across the UWL. The extent of improvement was correlated with the size of droplets: smaller droplets resulted in faster permeation rates. Addition of glyceryl tributyrate, while increasing the release rate, decreased the permeation rate due to formation of larger droplets. In conclusion, the addition of a plasticizer to an ASD containing a high Tg drug led to an improvement in release rate but increased the size of drug-rich nanodroplets produced via the release process with unknown potential implications for in vivo performance.
- Open Access
- 23 March 2026
- Published by Springer Nature in AAPS Open
- Vol. 12 (1)
Lyophilized monoclonal antibody (mAb) encoded mRNA—lipid nanoparticles (LNPs) lead to stable in vivo expression of mAb after room temperature storage
The recent success of mRNA COVID-19 vaccines using lipid nanoparticles (LNPs) underscores the potential of this technology for delivering gene-encoded biologics in humans. Passive immunization by in vivo expression of monoclonal antibodies (mAbs) could provide advantages over traditional vaccines due to its immediate protection and broader applicability. The use of mRNA allows for rapid development and easily scalable production, while in vivo expression of biologics (IVEB) reduces the complexity and cost associated with traditional mAb manufacturing by leveraging the body as a bioreactor. However, the requirement of cold chain storage and transportation remains a critical challenge for the distribution of mRNA-LNP formulations. Lyophilization of the mRNA-LNP formulations to produce dry powder offers a potential solution to this issue. In this study, we have investigated several lyophilization conditions for mRNA-LNP and evaluated their efficacy both in vitro and in vivo . Further physical stability and structure characterization provided insights into the structure-efficacy relationship. We successfully identified the lyophilization condition using 5 mM Tris buffer at pH 8 with 10% sucrose, which retained LNP particle size within an acceptable range, preserved mRNA encapsulation efficiency, and maintained consistent level of in vivo expressed mAbs after being stored at room temperature for a month.
- 23 March 2026
- Published by Springer Nature in AAPS Open
- Vol. 12 (1)
Open AccessLyophilized monoclonal antibody (mAb) encoded mRNA—lipid nanoparticles (LNPs) lead to stable in vivo expression of mAb after room temperature storage
The recent success of mRNA COVID-19 vaccines using lipid nanoparticles (LNPs) underscores the potential of this technology for delivering gene-encoded biologics in humans. Passive immunization by in vivo expression of monoclonal antibodies (mAbs) could provide advantages over traditional vaccines due to its immediate protection and broader applicability. The use of mRNA allows for rapid development and easily scalable production, while in vivo expression of biologics (IVEB) reduces the complexity and cost associated with traditional mAb manufacturing by leveraging the body as a bioreactor. However, the requirement of cold chain storage and transportation remains a critical challenge for the distribution of mRNA-LNP formulations. Lyophilization of the mRNA-LNP formulations to produce dry powder offers a potential solution to this issue. In this study, we have investigated several lyophilization conditions for mRNA-LNP and evaluated their efficacy both in vitro and in vivo . Further physical stability and structure characterization provided insights into the structure-efficacy relationship. We successfully identified the lyophilization condition using 5 mM Tris buffer at pH 8 with 10% sucrose, which retained LNP particle size within an acceptable range, preserved mRNA encapsulation efficiency, and maintained consistent level of in vivo expressed mAbs after being stored at room temperature for a month.
- 26 December 2023
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (2) , 103865
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
- 26 December 2023
- Published by Elsevier in Drug Discovery Today
- Vol. 29 (2) , 103865
Early evaluation of opportunities in oral delivery of PROTACs to overcome their molecular challenges
- 2 October 2023
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (10) , 4797-4799
Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside
- 2 October 2023
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 20 (10) , 4797-4799
Introducing the Molecular Pharmaceutics Special Issue on Industrial Drug Delivery─In Silico to Bedside
- Open Access
- 16 October 2021
- Published by Wiley in Nursing Open
- Vol. 9 (1) , 513-518
Workplace violence in primary hospitals and associated risk factors: A cross‐sectional study
Aim: To investigate the characteristics of workplace violence at primary hospitals in Southeast China and identify associated risk factors.Design: A cross‐sectional survey design was used for this work.Methods: We distributed a workplace violence questionnaire among medical staff at primary hospitals in Southeast Zhejiang Province, China. The data were collected between December 2016 and December 2017. We analysed the categorical data by using the chi‐square test and expressed it as frequencies. The risk factors were analysed by using multiple logistic regression analysis.Results: Among the 2,560 questionnaires, 1,842 (71.9%) medical staff indicated that they had experienced workplace violence. Verbal assault was the most common type, followed by physical and sexual assault. Furthermore, gender, age, marital status, education, technical position and number of hospital beds' numbers were independent risk factors.
- 16 October 2021
- Published by Wiley in Nursing Open
- Vol. 9 (1) , 513-518
Open AccessWorkplace violence in primary hospitals and associated risk factors: A cross‐sectional study
Aim: To investigate the characteristics of workplace violence at primary hospitals in Southeast China and identify associated risk factors.Design: A cross‐sectional survey design was used for this work.Methods: We distributed a workplace violence questionnaire among medical staff at primary hospitals in Southeast Zhejiang Province, China. The data were collected between December 2016 and December 2017. We analysed the categorical data by using the chi‐square test and expressed it as frequencies. The risk factors were analysed by using multiple logistic regression analysis.Results: Among the 2,560 questionnaires, 1,842 (71.9%) medical staff indicated that they had experienced workplace violence. Verbal assault was the most common type, followed by physical and sexual assault. Furthermore, gender, age, marital status, education, technical position and number of hospital beds' numbers were independent risk factors.
- 6 January 2017
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 8 (2) , 151-156
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1
High throughput screening and subsequent hit validation identified 4-isopropyl-3-(2-((1-phenylethyl)amino)pyrimidin-4-yl)oxazolidin-2-one as a potent inhibitor of IDH1R132H. Synthesis of the four separate stereoisomers identified the (S,S)-diastereomer (IDH125, 1f) as the most potent isomer. This also showed reasonable cellular activity and excellent selectivity vs IDH1wt. Initial structure–activity relationship exploration identified the key tolerances and potential for optimization. X-ray crystallography identified a functionally relevant allosteric binding site amenable to inhibitors, which can penetrate the blood–brain barrier, and aided rational optimization. Potency improvement and modulation of the physicochemical properties identified (S,S)-oxazolidinone IDH889 (5x) with good exposure and 2-HG inhibitory activity in a mutant IDH1 xenograft mouse model.
- 6 January 2017
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 8 (2) , 151-156
Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1
High throughput screening and subsequent hit validation identified 4-isopropyl-3-(2-((1-phenylethyl)amino)pyrimidin-4-yl)oxazolidin-2-one as a potent inhibitor of IDH1R132H. Synthesis of the four separate stereoisomers identified the (S,S)-diastereomer (IDH125, 1f) as the most potent isomer. This also showed reasonable cellular activity and excellent selectivity vs IDH1wt. Initial structure–activity relationship exploration identified the key tolerances and potential for optimization. X-ray crystallography identified a functionally relevant allosteric binding site amenable to inhibitors, which can penetrate the blood–brain barrier, and aided rational optimization. Potency improvement and modulation of the physicochemical properties identified (S,S)-oxazolidinone IDH889 (5x) with good exposure and 2-HG inhibitory activity in a mutant IDH1 xenograft mouse model.
- 1 June 2016
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 88, 191-201
Co-crystal formation based on structural matching
- 1 June 2016
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 88, 191-201
Co-crystal formation based on structural matching
- Top Cited PapersOpen Access
- 16 November 2011
- Published by Springer Nature in Nature
- Vol. 480 (7378) , 520-524
The Medicago genome provides insight into the evolution of rhizobial symbioses
Sequencing of Medicago truncatula, a model organism of legume biology, shows that genome duplications had a role in the evolution of endosymbiotic nitrogen fixation. Legumes are unusual among plants in that they can carry out endosymbiotic nitrogen fixation with rhizobial bacteria. The genome of Medicago truncatula (also known as barrel medic or barrel clover), a well-established model for the study of legume biology, has now been sequenced. Genome analysis shows that M. truncatula has undergone several rounds of whole-genome duplication, and that the duplication that took place approximately 58 million years ago played an important part in the evolution of endosymbiotic nitrogen fixation. Legumes (Fabaceae or Leguminosae) are unique among cultivated plants for their ability to carry out endosymbiotic nitrogen fixation with rhizobial bacteria, a process that takes place in a specialized structure known as the nodule. Legumes belong to one of the two main groups of eurosids, the Fabidae, which includes most species capable of endosymbiotic nitrogen fixation1. Legumes comprise several evolutionary lineages derived from a common ancestor 60 million years ago (Myr ago). Papilionoids are the largest clade, dating nearly to the origin of legumes and containing most cultivated species2. Medicago truncatula is a long-established model for the study of legume biology. Here we describe the draft sequence of the M. truncatula euchromatin based on a recently completed BAC assembly supplemented with Illumina shotgun sequence, together capturing ∼94% of all M. truncatula genes. A whole-genome duplication (WGD) approximately 58 Myr ago had a major role in shaping the M. truncatula genome and thereby contributed to the evolution of endosymbiotic nitrogen fixation. Subsequent to the WGD, the M. truncatula genome experienced higher levels of rearrangement than two other sequenced legumes, Glycine max and Lotus japonicus. M. truncatula is a close relative of alfalfa (Medicago sativa), a widely cultivated crop with limited genomics tools and complex autotetraploid genetics. As such, the M. truncatula genome sequence provides significant opportunities to expand alfalfa’s genomic toolbox.
- 16 November 2011
- Published by Springer Nature in Nature
- Vol. 480 (7378) , 520-524
Top Cited PapersOpen AccessThe Medicago genome provides insight into the evolution of rhizobial symbioses
Sequencing of Medicago truncatula, a model organism of legume biology, shows that genome duplications had a role in the evolution of endosymbiotic nitrogen fixation. Legumes are unusual among plants in that they can carry out endosymbiotic nitrogen fixation with rhizobial bacteria. The genome of Medicago truncatula (also known as barrel medic or barrel clover), a well-established model for the study of legume biology, has now been sequenced. Genome analysis shows that M. truncatula has undergone several rounds of whole-genome duplication, and that the duplication that took place approximately 58 million years ago played an important part in the evolution of endosymbiotic nitrogen fixation. Legumes (Fabaceae or Leguminosae) are unique among cultivated plants for their ability to carry out endosymbiotic nitrogen fixation with rhizobial bacteria, a process that takes place in a specialized structure known as the nodule. Legumes belong to one of the two main groups of eurosids, the Fabidae, which includes most species capable of endosymbiotic nitrogen fixation1. Legumes comprise several evolutionary lineages derived from a common ancestor 60 million years ago (Myr ago). Papilionoids are the largest clade, dating nearly to the origin of legumes and containing most cultivated species2. Medicago truncatula is a long-established model for the study of legume biology. Here we describe the draft sequence of the M. truncatula euchromatin based on a recently completed BAC assembly supplemented with Illumina shotgun sequence, together capturing ∼94% of all M. truncatula genes. A whole-genome duplication (WGD) approximately 58 Myr ago had a major role in shaping the M. truncatula genome and thereby contributed to the evolution of endosymbiotic nitrogen fixation. Subsequent to the WGD, the M. truncatula genome experienced higher levels of rearrangement than two other sequenced legumes, Glycine max and Lotus japonicus. M. truncatula is a close relative of alfalfa (Medicago sativa), a widely cultivated crop with limited genomics tools and complex autotetraploid genetics. As such, the M. truncatula genome sequence provides significant opportunities to expand alfalfa’s genomic toolbox.
- 1 August 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (16) , 4909-4912
The design, synthesis and structure–activity relationships of novel isoindoline-based histone deacetylase inhibitors
- 1 August 2011
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 21 (16) , 4909-4912
The design, synthesis and structure–activity relationships of novel isoindoline-based histone deacetylase inhibitors